Figure 2
Figure 2. SNP 6.0 array–based lesion cutoffs and TTFT or OS in CLL (Kaplan-Meier plots). (A-D) Previously untreated patient group was analyzed from trial enrollment for TTFT. (E-H) Previously untreated patient group was analyzed from trial enrollment for OS.

SNP 6.0 array–based lesion cutoffs and TTFT or OS in CLL (Kaplan-Meier plots). (A-D) Previously untreated patient group was analyzed from trial enrollment for TTFT. (E-H) Previously untreated patient group was analyzed from trial enrollment for OS.

Close Modal

or Create an Account

Close Modal
Close Modal